Loxo

News

Bayer takes control of Loxo duo as Lilly closes takeover

Bayer has acquired full rights to two drugs partnered with Loxo Oncology, on the same day that the biotech was taken over by Eli Lilly in an

News

Lilly further boosts cancer pipeline with $8bn Loxo acquisit...

In the second big M&A deal of the year following BMS’s acquisition

News

Bayer/Loxo drug approved in cancers with certain mutation

The FDA has approved Bayer and Loxo’s Vitrakvi (larotrectinib) for adults and children whose cancers have a specific genetic feature, or biomarker.

Views & Analysis

ASCO 2018 - Tuesday 5th June: Tesaro developing checkpoint c...

Breast cancer has been one area where checkpoint inhibitors have not yet gained traction – but that might be about to change following results announced by Tesaro at the American Society of

Bayer takes control of Loxo duo as Lilly closes takeover

Lilly further boosts cancer pipeline with $8bn Loxo acquisit...

Bayer/Loxo drug approved in cancers with certain mutation

ASCO 2018 - Tuesday 5th June: Tesaro developing checkpoint c...

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

Loxo

Editor's Picks